At What Cost?
Patient Impacts & Policy Imperatives Related to the IRA

On Wednesday, September 11, 2024, V-BID Center director, A. Mark Fendrick, took part in a discussion series hosted by the Partnership to Fight Chronic Disease. Speakers examined the Inflation Reduction Act’s impact on drug coverage, focusing on its intended and unintended effects, costs, and consequences.

Associated resources are available below.

IRA White Paper
How To Make Sure the IRA Works For All Patients
CMS Must Obtain Clinician Input To Prevent Access Barriers
CMS Should Do More To Fulfill The IRA's Promise To Lower Drug Costs